Pharma Stocks Soar: Nifty Pharma Jumps 0.62% Following Fed Rate Cut Surge

Pharmaceutical equities stage impressive comeback as Federal Reserve's rate decision sends sector soaring.
Market Momentum
The Nifty Pharma index rockets 0.62% higher—proof that even traditional sectors can catch a boost from monetary policy shifts. Investors pile into pharma names, betting on stability in uncertain times.
Fed's Calculated Move
Rate cuts inject fresh liquidity, pushing capital toward defensive plays. Pharma's rebound isn't just luck—it's a calculated response to cheaper money and persistent demand.
Wall Street's Ironic Twist
Because nothing says 'innovation' like scrambling back to bricks-and-mortar sectors when the Fed flinches. Sometimes the safest bet is the oldest game in town—even in a digital age.